Back to front
Section

Business

Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.

Adobe Named in Friday Analyst Research Roundup, but Key Rating Details Not Disclosed in Available Copy
The Apex Times

THE APEX TIMES

More Stories

Moderna shares back from a dip, but valuation concerns linger after mixed performance
The Apex Times

THE APEX TIMES

Business / The Apex Times

Moderna shares back from a dip, but valuation concerns linger after mixed performance

Moderna (MRNA) is trading around $49.64 after a recent rebound, with returns showing a mixed pattern over the past week and month. Analysts and traders watching the tape are now weighing whether the stock’s bounce has pushed it above what fundamentals would justify.

Jun 12, 7:43 AM EDT